MedTrace Logo

Support for COVID19 Patients at Home

NCT04898179 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 796

Last updated 2024-10-15

No results posted yet for this study

Summary

The rapid spread and increase of acute respiratory infection cases caused by the novel SARS-CoV-2 coronavirus represent a major challenge for healthcare systems around the world. The shortage of facilities and medical personnel is a major problem in the face of a serious epidemic. The Lombardy Region, and in particular the territories of Milan, Bergamo and Brescia, was the most affected due to the rapid increase in cases and limited medical resources during the initial phase of the epidemic.

The collaboration between hospital and territory with integrated communication systems and the monitoring of patients with appropriate technological tools that include telemedicine, are fundamental to ensure the continuity of care and the sustainability of the health system, also significantly reducing the risk of contagion for health professionals.

Conditions

  • COVID19 Patients

Interventions

OTHER

Telecare Group

Home-based telehealth program: telenursing and specialist teleconsultation Telemonitoring with a new pulse oximeter and specific App E-health platform Videoconference

OTHER

Control group

Usual care

Sponsors & Collaborators

  • Istituto Auxologico Italiano

    collaborator OTHER

  • Azienda Ospedaliera Bolognini di Seriate Bergamo

    collaborator OTHER

  • Azienda Socio Sanitaria Territoriale di Bergamo

    collaborator UNKNOWN

  • University of Bergamo

    collaborator OTHER

  • Istituti Clinici Scientifici Maugeri SpA

    lead OTHER

Principal Investigators

  • Simonetta Scalvini, MD · Istituti Clinici Scientifici Maugeri

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-12-31
Completion
2022-01-16

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04898179 on ClinicalTrials.gov